International Business Machines Corporation (NYSE:IBM) | IBM Research and Institute of Bioengineering and Nanotechnology Discover Breakthrough for Breast Cancer Drug Delivery

November 01, 2013 at 08:00 AM EDT

[PR Newswire] – SAN JOSE, Calif., Nov. 1, 2013 /PRNewswire/ — Today, scientists from IBM (NYSE: IBM) and Singapore’s Institute of Bioengineering and Nanotechnology (IBN) published a breakthrough drug-delivery technique, demonstrating the first . . . → Read More: International Business Machines Corporation (NYSE:IBM) | IBM Research and Institute of Bioengineering and Nanotechnology Discover Breakthrough for Breast Cancer Drug Delivery Similar posts: Company Update: Johnson & Johnson (NYSE:JNJ) – AstraZeneca to co-promote J&J prostate cancer drug in Japan [Reuters - UK Focus] – AstraZeneca has signed a deal... JPMorgan launches $3.3 billion physical commodity business sale – JPMorgan Chase & Co (NYSE:JPM) [Reuters] – JPMorgan Chase & Co has launched the sale... Company Update: The Boeing Company (NYSE:BA) – Boeing, Jetstar celebrate delivery of first 787 Dreamliner for Australia [PR Newswire] – EVERETT, Wash., Oct. 7, 2013 /PRNewswire/ —...

International Business Machines Corporation (NYSE:IBM) [PR Newswire] – SAN JOSE, Calif., Nov. 1, 2013 /PRNewswire/ — Today, scientists from IBM (NYSE: IBM) and Singapore’s Institute of Bioengineering and Nanotechnology (IBN) published a breakthrough drug-delivery technique, demonstrating the first biodegradable, biocompatible and non-toxic hydrogel that can deliver treatment more efficiently to people fighting breast cancer. Approximately 25% of all breast cancer patients have human epidermal growth factor receptor 2 … [visit site to read more]